Laszlo Wagner

7PUBLICATIONS
9CO-AUTHORS
Molecular targetsRespiratory diseasesCardiology (incl. cardiovascular diseases)Testing, assessment and psychometricsEcological impacts of climate change and ecological adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 08, 2025
Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease.

Dora B Balogh, Judit Hodrea, Adar Saeed

|Dec 09, 2023
Cardioprotective and Antifibrotic Effects of Low-Dose Renin-Angiotensin-Aldosterone System Inhibitors in Type 1 Diabetic Rat Model.

Dora B Balogh, Agnes Molnar, Arianna Degi

|Jul 29, 2023
The Sigma-1 Receptor Is a Novel Target for Improving Cold Preservation in Rodent Kidney Transplants.

Adam Hosszu, Akos R Toth, Tamas Lakat

|May 13, 2023
An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis.

Dora Bianka Balogh, Laszlo Jozsef Wagner, Andrea Fekete

|Feb 17, 2022
SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.

Judit Hodrea, Adar Saeed, Agnes Molnar

|Jun 21, 2020
Is it the time to apply the model of Czech-Austrian kidney paired donation program?

Adam Remport, Laszlo J Wagner, Miklos Z Molnar

Pageof 2

Frequent Collaborators

4 joint publications

Dora Bianka Balogh

2 joint publications

Lilla Lenart

1 joint publications

Miklos Z Molnar

1 joint publications

Adam Hosszu